Human albumin is effective in prevention of severe OHSS

References

• Waldenstrom U, Kahn J, Marsk L, Nilsson S. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by ‘prolonged coasting’ of very hyperstimulated patients: a multicentre study. Hum Reprod 1999; 14: 294–7.
   Google Scholar
• Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30: 225–68.
   Google Scholar
• Stewart JA, Hamilton PJ, Murdoch AP Thromboembolic disease associated with ovarian and assisted conception techniques. Hum Reprod 1997; 12: 2167–73.
   Google Scholar
• Rizk B, Smitz J. Ovarian hyperstimulation syndrome after superovulation for IVF and related procedures. Hum Reprod 1992; 7: 320–7.
   Google Scholar
• Haning RV Jr, Austin CW, Carlson IH et al. Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins. Fertil Steril 1983; 40: 31–6.
   Google Scholar
• Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988; 159: 210–15.
   Google Scholar
• Asch R, Ivery G, Goldsman M. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod 1993; 8: 1015–20.
   Google Scholar
• Isik AZ, Gokmen O, Zeyneloglu HB, Kara S, Keles G, Gulekli B. Intravenous albumin prevents moderate-severe ovarian hyperstimulation in in vitro fertilisation patients: a prospective randomized and controlled study. Eur J Obstet Gynecol Reprod Biol 1996; 70: 170–83.
   Google Scholar
• Chen CD, Wu MY, Yang JH, Chen SU, Ho HN, Yang YS. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. Fertil Steril 1997; 68: 287–91.
   Google Scholar
• Isik AZ, Ozgun OD, Kahraman S, Polat G, Vicdan K, Biberoglu K et al. Intravenous albumin combined with low dose human chorionic gonadotrophin and late step-down administration of menotropins are effective in prevention of severe ovarian hyperstimulation syndrome in high-risk patients in an in vitro fertilization program. Middle East Fertil Soc J 1997; 2/3: 238–42.
   Google Scholar
• Roberts JS, Bratton SL. Colloid volume expanders: Problems, pitfalls, and possibilities. Drugs 1998; 55: 621–30.
   Google Scholar
• Rainey TG, Read CA. Pharmacology of colloids and crystalloids. In: Chernow B (ed): The Pharmacologic Approach to the Critically Ill Patient. Baltimore MD: Williams and Wilkins, 1994: 272–90.
   Google Scholar
• Goldwaser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50: 693–703.
   Google Scholar
• Tullis JL. Albumin. Background and use. JAMA 1977; 237: 355–60.
   Google Scholar
• McClelland DB. Human albumin solutions. BMJ 1990; 300: 35–57.
   Google Scholar
• Emerson TE. Unique features of albumin: A brief review. Crit Care Med 1989; 17: 690–3.
   Google Scholar
• Shalev E, Giladi Y, Matilsky M, Ben-Ami M. Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in vitro fertilisation patients receiving intravenous albumin: a prospective study. Hum Reprod 1995; 10: 1373–6.
   Google Scholar
• Ludwig M, Jelkmann W, Bauer O, Diedrich K. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 1999; 14 (10): 2437–41.
   Google Scholar
• Shoham Z, Weissman A, Barash A, Borenstein R, Schachter M, Insler V. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilisation program: a prospective, randomised, placebo-controlled study. Fertil Steril 1994; 62: 137–42.
   Google Scholar
• Aboulghar M, Evers JH, Al-Inany H. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2000; (2): CD001302.
   Google Scholar
• Shaker AG, Zosmer A, Dean N, Berik JS, Jacob HS, Tan SL. Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril 1996; 65: 992–6.
   Google Scholar
• Orvieto R, Abir R, Kaplan B, Bar-Hava I, Ben-Rafael Z. The role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. A pilot experimental study. Clin Exp Obstet Gynecol 1999; 26 (2): 98–9.
   Google Scholar
• Ndukwe G, Thornton S, Fishel S, Dowell K, Aloum M. Severe ovarian hyperstimulation syndrome: is it really preventable by prophylactic intravenous albumin? Fertil Steril 1997 Nov; 68 (5): 851–4.
   Google Scholar
• Lewit N, Kol S, Ronen N, Itskovitz-Eldor J. Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome? Fertil Steril 1996 Oct; 66 (4): 654–6.
   Google Scholar
• Hillensjo T, Wikland M, Wood M. Albumin in the prevention of severe OHSS. Hum Reprod 1999; 14 (6): 1664–5.
   Google Scholar
• Cochrane Injuries Group Albumin Reviewers.. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 1998; 317: 235–40.
   Google Scholar
• Konig E, Bussen S, Sutterlin M, Steck T. Prophylactic intravenous hydroxyethyle starch solution prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized, double-blind and placebo-controlled study. Hum Reprod 1998; 13 (9): 2421–4.
   Google Scholar
• Graf MA, Fischer R, Naether OG, Baukloh V Tafel J, Nuckel M. Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyethyl starch solution in an in-vitro fertilization programme. Hum Reprod 1997; 12: 2599–602.
   Google Scholar